Cross Site Scripting vulnerability in the web application

published 2025-10-03 13 mo ago modified 2026-10-08 31 d ago also EUVD-2025-32483

cvss: 7.6; version 3.1, CNA
cisa kev: Not listed; not in CISA's catalog
epss: 0.3%; EPSS 0.3% chance of exploitation in 30 days, percentile 18%
public exploits: 0; none known

HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.

CISA SSVC

Exploitation: none
Automatable: no
Technical impact: partial
Assessed: 13 mo ago (2025-10-03)

Exploit prediction

0.27% chance of exploitation in the next 30 days, higher than 18% of all scored CVEs (FIRST EPSS, 2026-11-08).

CVSS scores

assigned by	version	score	vector
CNA	3.1	7.6	CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:H/I:L/A:H
NVD	3.1	5.4	CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

Affected products

HCL HCL MyXalytics

Classification

Weakness

CWE-79 Improper Neutralization of Input During Web Page Generation

References

support.hcl-software.com /csm?id=kb_article&sysparm_article=KB0124411
vendor-advisory

Sources

CVE List CVE-2025-52653
NVD CVE-2025-52653

Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.

Summary